Analogue Holdings Limited announced Dr. Mak, a non-executive Director and the deputy chairman of the Board, will be re-designated as a full time executive Director with effect from 1 March 2024. Following his re-designation, Dr. Mak will cease to be a member of the Audit Committee, the Nomination Committee and the Remuneration Committee of the Board with effect from 1 March 2024. Dr. Mak, aged 67, was appointed as a Director and the deputy chairman of the Board on 1 September 2017.

Dr. Mak was re-designated as a non-executive Director on 13 April 2018, acting in an advisory role in respect of the overall strategic planning for the Group and serving as a member of each of the Audit Committee, Nomination Committee and Remuneration Committee as well as a director of a subsidiary of the Company. On the effective date of his re-designation, Dr. Mak will also be appointed as Chairman. As a full time executive Director and Chairman, Dr. Mak will be responsible for developing, monitoring and evaluating the Group's business, and for the leadership, overall strategic planning and major decision making for the Group.

Dr. Mak obtained a master of business administration degree in May 1987 from City University, London, and a doctor of philosophy degree in May 1984 and a master of philosophy degree in December 1981 from University of Cambridge, United Kingdom. He also obtained a bachelor of engineering degree with first class honours in April 1980 from The University of Western Australia. Dr. Mak is a member of the Institution of Civil Engineers and the Institute of Marine Engineering, Science and Technology.

Dr. Mak is a member of the Labour Advisory Board and the Court of Baptist University. Dr. Mak is also the chairman of the Hong Kong Society for the Aged, the chairman of the English Schools Foundation, a general committee member of the Employers' Federation of Hong Kong. Dr. Poon, an executive Director and the current Chairman, will step down from his role as Chairman with effect from 1 March 2024, but will continue to serve as the Founder and an executive Director.

Dr. Mak has been appointed as the Chairman with effect from 1 March 2024. As the Group's Founder and a key member of the Board, Dr. Poon will continue to provide invaluable advice and support to the Group after stepping down as Chairman and will continue to contribute to the overall strategic planning and major decision making for the Group with special responsibility for the Lifts & Escalators business of the Group. Mr. Cheng, currently the chief financial officer of the Company and a senior management of the Group, has been appointed as an executive Director with effect from 1 March 2024.

Mr. Cheng, aged 60, was appointed as the chief financial officer (designate) of the Company on 16 September 2019 and took up the role of chief financial officer on 1 January 2020. He is also a director of certain subsidiaries of the Company. Mr. Cheng has extensive experience working as chief financial officer in overseas markets such as Europe, the Middle East, Africa and Latin America.

Prior to joining the Group, Mr. Cheng served as the chief financial officer of Hutchison Ports (Panama) and Hutchison Ports (Tanzania) within Hutchison Ports from 2013 to 2018. From 2011 to 2012, Mr. Cheng served as the finance director of PCCW Cascade Middle East Ltd. For over 10 years before 2011, Mr. Cheng held various roles as chief financial officer or finance director in the United Kingdom for various companies, namely Virgin Media Business (previously known as ntl:business), Aqiva (previously known as ntl:Broadcast), Multitone Electronics plc, i3 Group, etc. Mr. Cheng graduated from the University of Liverpool with a bachelor degree in Mechanical Engineering in 1986.

Mr. Cheng is also a fellow of the Chartered Institute of Management Accountants in the United Kingdom. Following his re-designation, Dr. Mak will cease to be a member of the Audit Committee, the Nomination Committee and the Remuneration Committee with effect from 1 March 2024. Ms. Or, a non-executive Director, has been appointed as a member of each of the Audit Committee, the Nomination Committee and the Remuneration Committee with effect from 1 March 2024.